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CORRESPONDENCE
Verocytotoxigenic Escherichia coli Serologic
Responses in Patients with Hemolytic Uremic
Syndrome
To the Editor—We read with interest the recent paper by Jelacic
et al. [1], in which they unsuccessfully sought a link between
ABO and P1 blood groups and outcomes of childhood infec-
tions by Escherichia coli O157. We would like to draw readers’
attention to our observations during an outbreak of hemolyt-
ic-uremic syndrome (HUS), in which we compared the num-
bers of seroreactivities to potential enterohemorrhagic E. coli
(EHEC)–related E. coli O antigens versus the total complica-
tions and the mean total complication score as determined clin-
ically by an independent observer.
Our results clearly show that, as the number of complications
increased or as the complication score increased, all mean sero-
reactivities also increased [2, 3]. This strongly supports the con-
clusion that multiple infections with a variety of verocytotox-
igenic E. coli (VTEC) contributed to the outbreak. It also
appears that the larger the variety of infecting VTEC, the
greater the possibility of complication.
We do not doubt the significance of EHEC O157 as an im-
portant cause of HUS and other human infections; however, until
such infections are thoroughly investigated—including testing for
the presence of non-O157 VTEC, which are known to be present
on meat derived from ruminant animals [4–6]—false interpre-
tations are likely.
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Reply
To the Editor—We thank Goldwater and Bettelheim [1] for
raising the possibility that some of the patients we reported [2]
from whom E. coli O157:H7 was isolated were also infected
with Shiga toxin–producing Escherichia coli (STEC) other than
E. coli O157:H7. However, two lines of evidence suggest that
the dual presence of O157:H7 and non-O157:H7 STEC is un-
common in the population we studied.
First, we recently completed a study in the Seattle Children’s
Hospital and Regional Medical Center (CHRMC) Emergency
Department, focusing on all STEC and not just on E. coli O157:
H7 [3]. We analyzed 5 sorbitol-fermenting colonies from the
sorbitol-MacConkey agar plates of 22 of the 28 children in-
fected with E. coli O157:H7 who presented to this facility during
a 3-year period (stool cultures from the remaining 6 patients
lacked sorbitol-fermenting colonies). None of the sorbitol-fer-
menting coisolated coliforms possessed stx genes. Eleven of
these 28 patients were also studied in our report [1]. Thus, if
non-O157:H7 STEC, which usually ferments sorbitol, infected
the patients whose stools contained sorbitol-nonfermenting E.
coli O157:H7, these organisms would comprise !20% of the
aerobic non-O157:H7 gram-negative flora
Second, in a 1991 study conducted in the CHRMC Micro-
biology Laboratory, 5 lactose-fermenting colonies were selected
and probed for the presence of stx genes, without their serotype
being known [4, 5]. In no case was a mixed STEC infection
identified. Thus, the use of a selection protocol that does not
bias toward the recovery of E. coli O157:H7 (non-O157:H7
STEC and E. coli O157:H7 almost always ferment lactose) did
not identify coinfections.
We agree that a subset of non-O157:H7 STEC are human
pathogens; they are underdetected by present screening tech-
niques, which usually rely on sorbitol-MacConkey agar. How-
ever, our data suggest that, if non-O157:H7 STEC are also
excreted by children in the Pacific Northwest who are infected
with E. coli O157:H7, then these organisms are considerably
less frequent among the coliform flora than are the E. coli O157:
H7 identified on the sorbitol-MacConkey agar plate.
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